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Abstract
Background: Massive postpartum hemorrhage is a life threatening obstetric emergency. In order to prevent the
complications associated with this condition, an organized and step-wise management protocol should be
immediately initiated.
Methods: An evidence based management protocol for massive postpartum hemorrhage was implemented at
Aga Khan University Hospital, Karachi, Pakistan after an audit in 2005. We sought to evaluate the compliance and
outcomes associated with this management protocol 3 years after its implementation. A review of all deliveries
with massive primary postpartum hemorrhage (blood loss ≥ 1500 ml) between January, 2008 to December, 2008
was carried out. Information regarding mortality, mode of delivery, possible cause of postpartum hemorrhage and
medical or surgical intervention was collected. The estimation of blood loss was made via subjective and objective
assessment.
Results: During 2008, massive postpartum hemorrhage occurred in 0.64% cases (26/4,052). No deaths were
reported. The mean blood loss was 2431 ± 1817 ml (range: 1500 - 9000 ml). Emergency cesarean section was the
most common mode of delivery (13/26; 50%) while uterine atony was the most common cause of massive
postpartum hemorrhage (14/26; 54%). B-lynch suture (24%) and balloon tamponade (60%) were used more
commonly as compared to our previously reported experience. Cesarean hysterectomy was performed in 3 cases
(12%) for control of massive postpartum hemorrhage. More than 80% compliance was observed in 8 out of
10 steps of the management protocol. Initiation of blood transfusion at 1500 ml blood loss (89%) and overall
documentation of management (92%) were favorably observed in most cases.
Conclusion: This report details our experience with the practical implementation of a management protocol for
massive postpartum hemorrhage at a tertiary care hospital in a developing country. With the exception of arterial
embolization, relatively newer, simpler and potentially safer techniques are now being employed for the
management of massive postpartum hemorrhage at our institution. Particular attention should be paid to the
documentation of the management steps while ensuring a stricter adherence to the formulated protocols and
guidelines in order to further ameliorate patient outcomes in emergency obstetrical practice. More audits like the
one we performed are important to recognize and rectify any deficiencies in obstetrical practice in developing
countries. Dissemination of the same is pivotal to enable an open discourse on the improvement of existing
obstetrical strategies.
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Primary postpartum hemorrhage (PPH) is the leading
cause of maternal morbidity and mortality especially in
developing countries where the availability of safe cesar-
ean procedures is not universal [1]. The incidence of pri-
mary PPH (blood loss ≥ 500 ml) at our institution has
been previously reported to be around 2.9% of all vaginal
deliveries [2].
Loss of 500 ml of blood in the first 24 hours following
delivery is generally considered as physiologically normal,
and anything exceeding that constitutes PPH. Significant
clinical deterioration usually does not occur until there is
a blood loss of > 1000 - 1500 ml [3,4]. “Massive” primary
PPH occurs when there has been an estimated blood loss
of ≥ 1500 ml, peri-partum fall in hemoglobin concentra-
tion > 4 g/dl or acute transfusion requirement of 4 units
of blood [5]. In our experience at a tertiary care hospital
in Pakistan, a developing country; massive PPH was
reported in 0.5% cases out of a total 4881 deliveries [2].
Massive primary PPH can result in maternal complica-
tions like hypovolemic shock, disseminated intravascular
coagulation, hepatic dysfunction, adult respiratory distress
syndrome and renal failure. In order to prevent these com-
plications, an organized and step-wise management proto-
col should be immediately initiated. It is important to be
cognizant of the fact that despite the growing body of
literature on the known risk factors for primary PPH, it
maybe inevitable in some cases. Hence, active manage-
ment of the third stage of labor should be offered to all
women. This includes the administration of uterotonic
agents, controlled cord traction, and uterine massage after
delivery of the placenta [6].
Immediate resuscitation with attempts to treat the
cause forms the cornerstone of management of PPH.
Evidence-based guidelines for the management of PPH
have been formulated in order to provide an organized
and standardized plan of care for the different scenarios
encountered in clinical practice [7].
We conducted a cross-sectional study in 2005 at a
tertiary care centre in Karachi whereby we retrospectively
reviewed the patient records to assess the current prac-
tices of the management of massive primary PPH in the
setting of a developing country. An indigenous protocol
was then devised based on the results of this audit to set
up a standard of care [see additional file 1] which was
applied at our institution. This protocol was implemen-
ted by sensitizing the obstetric and other related staff
through multiple presentations, drills and simulated sce-
narios. They were also taught the proper techniques and
skills for performing the different steps of the protocol.
This current paper aims to evaluate the compliance and
impact of our proposed management protocol three
years after its introduction at our institution.
Methods
Study setting and design
A review of deliveries with massive primary PPH at Aga
Khan University Hospital (AKUH), Karachi, Pakistan
between January, 2008 to December, 2008 was carried
out. AKUH, Karachi, established in 1985 as a part of the
Aga Khan Development Network, is a philanthropic
teaching tertiary care hospital in Pakistan. This 563-bed
hospital has 15 inpatient units including a dedicated
Obstetrics and Gynecology unit. The hospital provides
health care services to 50,000 inpatients and 600,000
outpatients annually from all over Pakistan. The average
length of stay for hospitalized patients is 3.4 days at
AKUH, Karachi. The hospital has a total of 19 surgical
theatres; 11 of these theatres are the main operating
theatres while the remaining theatres are used for proce-
dures done as daycare, in the emergency room or the
community health center. The Obstetrics and Gynecol-
o g yu n i to fA K U H ,K a r a c h i ,c o m p r i s e so f8 8b e d sw i t h
12 bedded labor and delivery suites and a 24 hours
obstetric operating service. This is a consultant-led
maternity service, staffed with experienced midwives,
resident nurses, postgraduate trainees, on floor registrars
and specialist registrars. Normal deliveries are con-
ducted by the senior postgraduate trainee. These are
defined as spontaneous vaginal deliveries (SVDs) with-
out any complications. Overall, the cesarean section rate
at AKUH is 25%. The maternal mortality rate (MMR) in
2008 was 132.9 per 100,000 live births (all unbooked
maternal deaths) while the perinatal mortality rate
( P M R )f o rt h es a m et i m ep e r i o dw a s5 . 8 4p e r1 , 0 0 0l i v e
births.
Regarding drills and teaching programs for emergency
obstetric care, the unit at AKUH is certified by the
American College of Family Physicians for Advanced
Life Support in Obstetrics (ALSO) since 2002. Since
then, ALSO training courses are conducted regularly
twice a year for the health care professionals involved in
the provision of obstetric care. More generalized but
structured teaching activities such as drills and work-
shops are also conducted for the trainees on a regular
basis.
Inclusion criteria
Only booked deliveries with massive primary PPH were
included. Massive primary PPH was defined as blood
loss ≥ 1500 ml.
Estimation of blood loss
The estimation of blood loss was made via subjective as
well as objective assessment. Subjective measures
included counting of soaked swabs, estimation of blood
clots and blood in the suction bottle whereas objective
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reduction in hemoglobin level or evaluation of the need
for blood transfusions [2]. Active management of the
third stage of labour is offered to all women delivering
at our institution [2].
Data management and statistical analysis
We reviewed the charts of all patients who fulfilled our
inclusion criteria and gathered data on a structured,
pre-tested proforma prepared for the purpose [see addi-
tional file 2]. Information regarding mortality, mode of
delivery, possible cause of PPH and therapeutic medical
or surgical intervention was collected. The data obtained
from the file review were coded and entered in SPSS
version 16.0 for analysis. Descriptive statistics have been
presented for a consecutive series of patients with
massive primary PPH.
Ethical considerations
The protocol of this study was granted exemption from
the Ethical Review Committee (ERC) at AKUH because
of its retrospective design (as per guidelines of the
ERC). Informed consent was not needed owing to the
anonymous presentation of the patient data; this was
also in accordance with the guidelines of ERC at AKUH.
Results
Twenty six patients fulfilled the inclusion criteria for
this study. During 2008, there were a total of 4052 deliv-
eries at AKUH, Karachi; therefore massive PPH
occurred in less than 1% (26/4052) of cases during 2008.
No deaths were reported. The mean blood loss was
2431 ± 1817 ml (range: 1500 - 9000 ml).
Mode of delivery
Among the 26 patients, emergency cesarean section (CS)
was the most common mode of delivery (13/26, 50%) fol-
lowed by spontaneous vaginal delivery with episiotomy
(6/26, 23%) and elective CS (3/26, 12%). Forceps delivery
with episiotomy and vacuum delivery with episiotomy
each occurred in 2 out of 26 cases (8%).
Cause of PPH
Uterine atony alone was the most common cause of
massive PPH in our series (14/26; 54%). Seven patients
out of 26 (27%) underwent CS for placenta previa; they
experienced massive bleeding from the placental bed
after removal of placenta. Out of these seven patients,
three had elective CSs and four were operated in emer-
gency due to antepartum hemorrhage secondary to
major previa. All the previa were antenatally diagnosed.
Two patients out of the seven underwent cesearean hys-
terectomy to control bleeding. Four patients out of
26 (15%) had retained placenta and underwent manual
removal of retained placenta (MROP); atony occurred in
these patients after MROP. One patient out of 26 (4%)
had trauma in the form of cervical and vaginal tear; this
was due to failed vacuum delivery followed by forceps
delivery. Bleeding in this patient was eventually con-
trolled by examination under anesthesia (EUA) and
suturing. EUA entails a reliable and detailed examina-
tion of the cervix, vagina and uterine cavity under
anesthesia.
Compliance with steps of management protocol
The compliance with the steps of management protocol
in cases of massive PPH during 2008 at AKUH, Karachi
is shown in table 1. It was seen that “call for help”,a sa
step of the management protocol, was followed in all 26
cases (100%). Either a consultant was already present on
the spot or was called upon as soon as PPH occurred.
Checking vitals of the patient during the management of
PPH was not documented in 5 of the 26 cases (19%); all
of these cases were managed in the labour room after
vaginal delivery. Similarly, the cases where documenta-
tion of maintaining two peripheral cannulas and fluids
was missing had deliveries in the labour room. Foley’s
catheter was placed immediately to record urinary out-
put in all 26 cases except one; this patient had PPH sec-
ondary to cervical and vaginal tears after failed vacuum
delivery followed by instrument assisted delivery. She
was later shifted to the operation theatre for EUA. After
suturing of the tears, she was catheterized. Performance
of uterine massage was not documented in 4 of the 26
cases (15%); two of these patients underwent lower seg-
ment CS (LSCS), one had MROP and atony after
MROP while one had cervical and vaginal tears follow-
ing forceps delivery. Placental examination was not done
in 9 out of 26 patients (35%). This was either not
Table 1 Compliance with steps of management protocol
for massive PPH (n = 26)
Step of protocol Frequency
(%)
1. Call for help 26 (100)
2. Check vitals 21 (80.8)
3. Two I/V* cannula 21 (80.8)
4. I/V fluids/colloid 25 (96.2)
5. Cross match blood and labs sent 23 (88.5)
6. Foley’s catheterization done 25 (96.2)
7. Uterine massage done 22 (84.6)
8. Genital inspection performed 25 (96.2)
9. Placental inspection done 17 (65.4)
10. EUA and proceed (for trauma/placental removal/
hematoma)
6 (23.1)
*I/V - Intravenous.
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removal of morbidly adherent placenta.
Table 2 shows the general management of patients
with massive PPH at our institution. It was seen that
overall documentation of management, tailoring recov-
ery phase according to the specific condition of the
patient initiation of blood transfusion were the manage-
ment steps that were most consistently followed overall.
Management of uterine atony
A total of 25 out of the 26 cases (96%) had uterine
atony with or without association with other conditions;
this includes cases that had uterine atony after MROP
or severe placental bed bleeding. Table 3 shows compli-
ance with the steps in our institutional protocol with
regards to the management of cases with uterine atony.
Only 2 out of 26 patients (8%) underwent “examination
under anesthesia and proceed”. One of these patients
had spontaneous vaginal delivery with episiotomy; she
was diagnosed as having atony after EUA. The other
patient underwent CS and had heavy per vaginal bleed-
ing; she underwent balloon tamponade and vaginal
packing under EUA. It was noted that no patient had
primary laparotomy for atony; although two patients
had intra-abdominal packing done after CS. These
patients had re-laparotomy after 48 hours interval for
the removal of abdominal packs. Internal iliac vessel
ligation was not performed in any patient. Cesarean hys-
terectomy was done in a total of 3 patients (12%). Two
of these patients had LSCS for placenta previa that was
morbidly adherent; these patients also had urinary blad-
der injury during the process which was repaired
primarily. The third patient had uterine atony and
received hysterectomy.
Discussion
PPH, a leading cause of maternal mortality, causes an
estimated 140,000 deaths each year globally - this
roughly corresponds to one woman dying every 4 min-
utes. In addition, serious morbidity may follow PPH in
the form of various sequelae [8,9]. Massive PPH is
associated with a worse prognosis. Inability to stabilize a
patient who is in hemorrhagic shock can eventually
result in death [8].
Incidence of massive PPH
The incidence of massive PPH in this audit was 0.64% of
all booked deliveries in 2008 at AKUH, Karachi, Paki-
stan. This figure was slightly higher but certainly com-
parable to that reported in our previous experience
three years ago (0.5%) [2]. However, it was lower when
compared to population-based studies where the inci-
dence of massive PPH has been reported to be as high
as 1.1% [10]. In a recent review, PPH was also found to
have an increasing trend in the more developed parts of
the world including Australia, Canada, the UK and the
USA [11]. Although the exact reasons for this increasing
trend remain nebulous, the authors of this review identi-
fied certain associated factors such as increasing mater-
nal age at childbirth and increase in induced labor, CS
and multiple pregnancies [11].
Mode of delivery
In our previous experience, 56% (18/32) of the women
who had massive PPH delivered vaginally. In our more
recent experience, the mode of delivery in half of our
cases of massive PPH was CS. This association between
massive PPH and CS is comparable to other studies,
where the highest risk of massive PPH has been reported
for pre-labor CS and emergency CS, especially in mothers
with previous CS. Hence, caution and vigilance for mas-
sive PPH should be exercised with pre-labor and emer-
gency CS [10].
Causes of PPH
Uterine atony, lower genital tract lacerations, uterine
rupture or inversion, retained products of conception
Table 2 General management of the patients (n = 26)
with PPH
General management steps Frequency
(%)
1. Initiation of blood transfusion at 1500 ml 23 (88.5)
2. Multidisciplinary approach acquired 9 (34.6)
3. Overall documentation of management 24 (92.3)
4. Documentation of counseling after management
(patient or family)
18 (69.2)
5. Recovery phase followed according to patient’s
condition
26 (100)
Table 3 Management steps followed in cases of uterine
atony (n = 25)
Steps of protocol Frequency (%)
1. Syntocinon 10 units (upto four doses given) 24 (96.0)
2. Syntocinon infusion (40 units) started 25 (100)
3. Misoprostol (600-800 mcg) 18 (72.0)
4. PGF2 alpha (5 mg) 4 (16.0)
5. Balloon tamponade 15 (60.0)
6. EUA done and proceeded 2 (8.0)
7. Uterine/vaginal packing done 8 (32.0)
8. Syntocinon infusion (80 units) started 16 (64.0)
9. Laparotomy for atony performed 0 (0)
10. B- lynch suture applied 6 (24.0)
11. Internal iliac vessel ligation 0 (0)
12. Hysterectomy performed 3 (12.0)
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causes of PPH [9]. By far the most common etiology is
uterine atony - this also emerged as the most common
cause of massive PPH in our study. Other causes that
we observed include placental adhesion, retained
placenta and cervical or vaginal tears. This is compar-
able to our results three years ago when uterine atony
was the most common cause, followed by vaginal hae-
matoma, cervical or vaginal tears, adherent placenta,
uterine angle extension and retained placenta [2].
Management of massive PPH
Timely recognition and intervention are fundamental in
preventing serious maternal morbidity and mortality from
massive PPH. A combination of conservative therapies is
adequate and successful in most cases. However, when the
hemorrhagic process continues and when either clotting
abnormalities or hemodynamic instability develop, the
next step must be an invasive intervention [12].
a. Compliance with protocol
In order to improve the management of massive PPH, we
proposed a treatment protocol for the management of
PPH that has been described earlier [2]. We compared
the individual steps of this protocol in terms of compli-
ance. In 8/10 steps, the documented compliance of more
than 80% was observed; this is indicative of generally
compliant practices at our institution. Our outcomes
were improved because no morality occurred during
2008 from massive PPH. In comparison, there was one
death (3.1%) in our previous study [2].
b. Transfusion of blood products
Traditional blood components, including packed red
blood cells, platelets, plasma, and cryoprecipitate, should
be used in patients with significant bleeding. Recent stu-
dies underline the utility of transfusing these components
in defined ratios to prevent dilutional coagulopathy.
Disseminated intravascular coagulation (DIC) should be
considered in severely bleeding obstetric patients and
should be treated aggressively using blood components.
About 88% of the patients in our study required blood
transfusions. This is higher compared to our experience
three years back, when blood transfusions were required
in 56% of women who had massive postpartum hemor-
rhage [2]. This finding can be explained by the fact that
adherence to a formulated protocol this time provided a
more objective approach to the evaluation for the need of
transfusion.
c. Recombinant factor VII
Newer hemostatic agents, such as activated factor VII,
will play significant roles in patients with bleeding that is
refractory to standard therapy [13]. In our series, two
patients received recombinant factor VII; the number of
d o s e sg i v e nw a s1( 1 . 2m g )a n d2( 1 . 2×2=2 . 4m g )
respectively. Hemorrhage was controlled in both patients
within 45 to 60 minutes without any adverse effects
observed. Both patients had placenta percreta; hysterect-
omy was indicated in both patients and was then done
electively. Post delivery, the bleeding in these patients
was controlled via pelvic packing, replacement of clotting
factors and ultimately through the use of recombinant
factor VII. The patients stabilized after receipt of the
latter therapy. The decision to administer factor VII in
these patients was made in consultation with the hema-
tologist, anesthesiologist and obstetrician. The intention
of giving factor VII in these patients was not the preven-
tion of hysterectomy but rather the control of massive
and life threatening PPH. It has been shown in a Paki-
stan-based study that activated recombinant factor VII
can be a life-saving drug in patients with massive PPH
[14]. Although implementation of a management proto-
col for obstetric bleeding that integrates new knowledge
in coagulation may aid physicians in improving outcomes
for the mother as well as the baby [13], consideration
also needs to be given to the ubiquitous availability of
these newer modalities.
d. Misoprostol
Misoprostol, a prostaglandin analog, is absorbed effec-
tively from rectal as well as oral and vaginal mucosa.
Rectally administered misoprostol appears to be an effec-
tive treatment for postpartum hemorrhage unresponsive
to oxytocin and ergometrine. Given that it is an inexpen-
sive and stable drug, misoprostol has considerable poten-
tial to reduce maternal mortality from postpartum
hemorrhage in developing countries like Pakistan [15].
Based on the recommendations of a recent meta-analysis
[16], a single dose of misoprostol (600 micrograms, oral
o rs u b l i n g u a l )s h o u l db eu s e di ni n s t a n c e sw h e no t h e r
treatments have either failed to work or are not available.
A similar study from Pakistan [17] further supports miso-
prostol’s promise as an adjunct treatment option for
PPH. We used misoprostol in 72% of our massive PPH
cases with good results.
e. B-Lynch suture
The B-Lynch surgical technique for the management of
massive PPH has been used successfully since 1989. It
allows for conservation of the uterus for subsequent
menstrual function and pregnancies; hence it is pre-
ferred over hysterectomy [18,19]. We managed 24% of
our massive PPH cases using B-Lynch sutures, and we
strongly recommend this technique based on our suc-
cessful experience.
f. Balloon tamponade
Intrauterine tamponade with balloon catheter is another
option that can be employed for the management of
massive PPH. A study of patients with severe PPH who
were managed with this technique has been reported in
literature. Although the tamponade was effective in
most cases, 10% of the cases required hysterectomy
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used balloon tamponade effectively in 60% of our
patients, and it served as a useful adjunct option. In
contrast, very few cases employed balloon tamponade
(2 cases) and compression sutures (2 cases) in our pre-
vious audit [2].
g. Arterial embolization
Arterial embolization can be a suitable management
option in selected patients with massive PPH, especially
in cases where the initial measures have failed and the
patient desires fertility. In such patients, an active effort
should first be made to investigate potentially correct-
able causes of massive PPH through trial of uterotonic
drugs, the exploration of the uterine cavity, cervix,
vagina and inspection of the perineum. Uterine artery
embolization can also be considered electively to reduce
blood loss in already diagnosed cases of major previas
and morbidly adherent placenta. None of our patients
with massive PPH were managed via embolization and
this treatment option may have been underutilized at
our institution. In an experience with 36 cases of severe
PPH, arterial embolization was associated with immedi-
ate success in all cases. Rare complications from the
procedure include puncture site false aneurysm, regres-
sive lower limb paraesthesia, femoral vein thrombosis,
and minor puncture site hematomas [21].
Strengths and limitations
Based on our indigenous experience, we developed a
management protocol three years ago for the purpose of
improving management of massive PPH. This protocol
was designed with special reference to the unique needs
and perspectives of developing countries. We have now
presented our current experience with its implementa-
tion in actual obstetric practice in order to evaluate the
feasibility and compliance with this protocol.
This protocol serves as an evidence based model that
can reduce practice variability and set up a more uni-
form standard of care, especially in developing countries.
This study is important in terms of describing the
trends observed with a management protocol of massive
PPH in the setting of a developing country.
We acknowledge that the short duration of the study
period and small sample size are the limitations of this
study. PPH is one of the top most causes of maternal
mortality in a developing country like ours. Larger scale
studies are required at different tertiary care hospitals of
Pakistan in order to acquire a better and more holistic
picture of the impact of this management protocol.
Another limitation of this study is that although the
compliance of our overall practices was assessed, indivi-
dual practices of all health care workers involved in the
management were not evaluated separately.
Conclusions
In conclusion, massive PPH is an obstetric emergency
that can occur following vaginal delivery or CS. In
order to prevent fatal complications, prompt diagnosis
and management is imperative in all cases of massive
PPH. Three years back, more conventional techniques
were opted for at our institution, probably due to less
familiarity and experience with the newer and perhaps
simpler techniques. After the implementation of this
protocol in routine management at our hospital, the
latter were more frequently employed with the excep-
tion of arterial embolization. It should be emphasized
that particular attention needs to be accorded to the
documentation of the management steps for better
medico-legal practice in developing countries. Addi-
tionally, stricter adherence to formulated protocols
and guidelines is important to further improve out-
comes in patients with massive PPH. Lastly, more
audits like the one we performed are important to
recognize and rectify any deficiencies in obstetrical
practice. Dissemination of the same is pivotal to
enable an open discourse on the improvement of exist-
ing obstetrical strategies.
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